Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 2
2016 1
2017 3
2018 2
2019 2
2020 2
2021 1
2022 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological interactions of monoclonal antibodies.
Serra López-Matencio JM, Morell Baladrón A, Castañeda S. Serra López-Matencio JM, et al. Among authors: morell baladron a. Med Clin (Barc). 2018 Aug 22;151(4):148-155. doi: 10.1016/j.medcli.2017.10.037. Epub 2017 Dec 27. Med Clin (Barc). 2018. PMID: 29269128 Review. English, Spanish.
Biosimilars: A new scenario in biologic therapies.
Serra López-Matencio JM, Morell Baladrón A, Castañeda S. Serra López-Matencio JM, et al. Among authors: morell baladron a. Reumatol Clin. 2017 Sep-Oct;13(5):287-293. doi: 10.1016/j.reuma.2016.05.013. Epub 2016 Jun 29. Reumatol Clin. 2017. PMID: 27372258 Free article. Review. English, Spanish.
JAK-STAT inhibitors for the treatment of immunomediated diseases.
Serra López-Matencio JM, Morell Baladrón A, Castañeda S. Serra López-Matencio JM, et al. Among authors: morell baladron a. Med Clin (Barc). 2019 May 3;152(9):353-360. doi: 10.1016/j.medcli.2018.10.020. Epub 2018 Dec 4. Med Clin (Barc). 2019. PMID: 30527218 Review. English, Spanish.
How to select a nanosimilar.
Astier A, Barton Pai A, Bissig M, Crommelin DJA, Flühmann B, Hecq JD, Knoeff J, Lipp HP, Morell-Baladrón A, Mühlebach S. Astier A, et al. Among authors: morell baladron a. Ann N Y Acad Sci. 2017 Nov;1407(1):50-62. doi: 10.1111/nyas.13382. Epub 2017 Jul 17. Ann N Y Acad Sci. 2017. PMID: 28715605 Free article.
Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.
González-Álvaro I, Martínez-Fernández C, Dorantes-Calderón B, García-Vicuña R, Hernández-Cruz B, Herrero-Ambrosio A, Ibarra-Barrueta O, Martín-Mola E, Monte-Boquet E, Morell-Baladrón A, Sanmartí R, Sanz-Sanz J, de Toro-Santos FJ, Vela P, Román Ivorra JA, Poveda-Andrés JL, Muñoz-Fernández S; Spanish Rheumatology Society; Spanish Rheumatology Society. González-Álvaro I, et al. Among authors: morell baladron a. Rheumatology (Oxford). 2015 Jul;54(7):1200-9. doi: 10.1093/rheumatology/keu461. Epub 2014 Dec 19. Rheumatology (Oxford). 2015. PMID: 25526976 Free PMC article.
Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis.
Llaneza González M, Carrascal Rueda P, Delgado Sánchez O, Borges Guerra M, Rodríguez Antigüedad A, Morell Baladrón A, Becerril Ríos N, Rovira À, Meca Lallana V, Benedito-Palos L, Comellas M, Vilanova D, Echeto A, Pérez X, Oreja-Guevara C. Llaneza González M, et al. Among authors: morell baladron a. Mult Scler Relat Disord. 2024 Apr;84:105501. doi: 10.1016/j.msard.2024.105501. Epub 2024 Feb 13. Mult Scler Relat Disord. 2024. PMID: 38401203 Free article. Review.
A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study).
de Andrés-Nogales F, Cruz E, Calleja MÁ, Delgado O, Gorgas MQ, Espín J, Mestre-Ferrándiz J, Palau F, Ancochea A, Arce R, Domínguez-Hernández R, Casado MÁ; FinMHU-MCDA Group. de Andrés-Nogales F, et al. Orphanet J Rare Dis. 2021 Apr 26;16(1):186. doi: 10.1186/s13023-021-01809-1. Orphanet J Rare Dis. 2021. PMID: 33902672 Free PMC article.
Effectiveness, Toxicity, and Survival Predictors of Regorafenib in Metastatic Colorectal Cancer: A Multicenter Study of Routinely Collected Data.
Calvo-García A, Abánades MP, Ruíz-García S, Román ABF, Fernández JL, García BC, Terciado CH, Álvarez RS, Solis RM, Marin BH, Diez PT, Baladrón AM, Bosch RC. Calvo-García A, et al. Among authors: baladron am. Oncology (Williston Park). 2022 Dec 20;36(12):732-738. doi: 10.46883/2022.25920981. Oncology (Williston Park). 2022. PMID: 36548097 Free article.
Factors associated with long-term persistence of rituximab in rheumatoid arthritis In clinical practice: RITAR Study.
Cañamares Orbis I, Merino Meléndez L, Llorente Cubas I, Benedí González J, García-Vicuña R, Morell Baladrón A, González-Álvaro I, Ramírez Herraiz E. Cañamares Orbis I, et al. Among authors: morell baladron a. Med Clin (Barc). 2020 Jul 10;155(1):1-8. doi: 10.1016/j.medcli.2019.09.021. Epub 2019 Dec 15. Med Clin (Barc). 2020. PMID: 31848023 English, Spanish.
14 results